Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein-Reference-Cited by-同舟云学术

Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein

Published:2013-03 Issue:3 Volume:54 Page:602-614
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Lee Richard G.,Fu Wuxia,Graham Mark J.,Mullick Adam E.,Sipe Donna,Gattis Danielle,Bell Thomas A.,Booten Sheri,Crooke Rosanne M.

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference39 articles.

1. Deaths: leading causes for 2004;Heron;Natl. Vital Stat. Rep.,2007

2. Very-low-density lipoprotein assembly and secretion;Shelness;Curr. Opin. Lipidol.,2001

3. An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis;Crooke;J. Lipid Res.,2005

4. Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice;Mullick;J. Lipid Res.,2011

5. Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes;Koller;Nucleic Acids Res.,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tripterygium glycosides improve abnormal lipid deposition in nephrotic syndrome rat models;Renal Failure;2023-03-06

2. Low-protein diet during gestation and lactation increases hepatic lipid accumulation through autophagy and histone deacetylase;American Journal of Physiology-Endocrinology and Metabolism;2020-07-01

3. Nuclear envelope–localized torsinA-LAP1 complex regulates hepatic VLDL secretion and steatosis;Journal of Clinical Investigation;2019-10-07

4. Harnessing nucleic acid-based therapeutics for atherosclerotic cardiovascular disease: state of the art;Drug Discovery Today;2019-05

5. Heparin-binding EGF-like growth factor (HB-EGF) antisense oligonucleotide protected against hyperlipidemia-associated atherosclerosis;Nutrition, Metabolism and Cardiovascular Diseases;2019-03